Centered around a presentation on cardiovascular disease prevention and management in prostate cancer by Laurence Klotz, MD, FRCSC, of the University of Toronto, expert physicians Evan Goldfischer, MD, MBA, FACS; Daniel George, MD; and Lawrence Karsh, MD, provide insight on evolving strategies in patient education, lifestyle modification, multidisciplinary care, and more.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

Chapters

Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen Deprivation Therapy With Prostate Cancer

Insight from Evan R. Goldfischer, MD, MBA, FACS

Evan R. Goldfischer, MD, MBA, FACS, shares his perspective on the optimal management of prostate cancer in the context of cardiovascular risk and comorbidity.

Insight from Daniel J. George, MD

Daniel J. George, MD, reflects on the current treatment paradigm of cardiovascular disease management in patients being treated for prostate cancer.

Insight from Lawrence I. Karsh, MD

Lawrence I. Karsh, MD, draws on his personal experience to discuss the optimal management of prostate cancer in the context of cardiovascular disease.

Insight from Anees Daud, MD

Anees Daud, MD, shares his perspective on cardiovascular disease prevention and management in patients with prostate cancer.

Additional Resources

RECAP: Cardiovascular Disease in Men With Prostate Cancer Who Are Receiving Androgen Deprivation Therapy

SLIDES: Understanding Risk Factors of Cardiovascular Disease and Management Guidance for Men on Androgen Deprivation Therapy With Prostate Cancer

AUA West 2019: Practice Patterns and the Role of Testosterone In Prostate Cancer

Androgen Deprivation Therapy (ADT): Benefits of Long-Term Use and Managment of Risks

Practice Patterns and the Role of Testosterone In Prostate Cancer